☆ 4.6 Article

An attenuated vaccinia vaccine encoding the severe acute respiratory syndrome coronavirus-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human angiotensin-converting enzyme 2 transgenic mice from severe acute respiratory syndrome coronavirus-2 and its variants

FRONTIERS IN MICROBIOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination

Hideaki Kato et al.

Summary: Research showed that antibody levels of vaccine-induced humoral and cell-mediated immunity significantly decreased at 6 months post two doses of BNT162b2 vaccination. However, a certain level of cellular immunity was still observed regardless of age and alcohol consumption.

VACCINE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Multi-organ proteomic landscape of COVID-19 autopsies

Xiu Nie et al.

Summary: This study used proteomic analysis to reveal the molecular mechanisms of multi-organ injuries in COVID-19 patients. The data showed significant upregulation of cathepsin L1 in the lung, instead of ACE2. Systemic hyperinflammation, dysregulation of glucose and fatty acid metabolism were detected in multiple organs.

CELL (2021)

添加到收藏夹

Article Virology

COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice

Juan Garcia-Arriaza et al.

Summary: Two COVID-19 vaccines based on MVA vectors induced robust and polyfunctional T-cell responses and neutralizing antibody titers in mice, providing protection against SARS-CoV-2. The results demonstrate the full efficacy of MVA-based COVID-19 vaccines in animal models and support their translation to clinical use.

JOURNAL OF VIROLOGY (2021)

添加到收藏夹

Article Immunology

Epicutaneous immunization with modified vaccinia Ankara viral vectors generates superior T cell immunity against a respiratory viral challenge

Youdong Pan et al.

Summary: Studies have demonstrated that MVA vaccination through skin scarification generates a greater number of T cells with unique transcriptional characteristics, providing more effective protection against lethal respiratory virus challenges in mice.

NPJ VACCINES (2021)

添加到收藏夹

Article Immunology

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Nanda Kishore Routhu et al.

Summary: The study demonstrates that MVA/S vaccination induces strong neutralizing antibody and T cell responses, providing protection against SARS-CoV-2 in mice and macaques. Single-cell RNA sequencing analysis of lung cells reveals that the vaccination also protects macaques from infection-induced inflammation and B cell abnormalities.

IMMUNITY (2021)

添加到收藏夹

Article Medicine, General & Internal

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months

Einav G. Levin et al.

Summary: A study in Israel revealed that waning immunity after receiving two doses of the BNT162b2 vaccine led to an increase in the incidence of SARS-CoV-2 infection. Levels of spike-binding IgG and neutralizing antibodies decreased more significantly in men, individuals aged 65 or older, and immunosuppressed individuals in a longitudinal study involving nearly 4000 healthcare workers.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection

Ruikang Liu et al.

Summary: Research on modified vaccinia virus Ankara (MVA) expressing the S protein of SARS-CoV-2 showed promising results in inducing antibodies and CD8+ T cells, protecting transgenic mice from lethal infection, preventing nasal infection, reducing cytokine expression, and effectively terminating virus replication in vaccinated animals.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Virology

Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques

Hirohito Ishigaki et al.

Summary: Cynomolgus macaques were used to establish an animal model of COVID-19 to develop vaccines and antiviral drugs, showing similar symptoms to human patients. The study found that both neutralizing antibodies and cellular immunity play important roles in eliminating SARS-CoV-2.

VIROLOGY (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia

Douglas B. Cines et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey

Mine Durusu Tanriover et al.

Summary: The study presented the interim efficacy and safety results of the CoronaVac vaccine in a phase 3 clinical trial in Turkey, demonstrating high efficacy against PCR-confirmed symptomatic COVID-19 with good safety and tolerability profile. Results showed significant differences in the frequency of any adverse events between the vaccine and placebo groups, indicating excellent protective effects of the vaccine.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Alejandro Jara et al.

Summary: A study in Chile involving 10.2 million participants assessed the effectiveness of an inactivated SARS-CoV-2 vaccine developed in China. Fully immunized individuals had vaccine effectiveness of 65.9% for preventing Covid-19 and 87.5% for preventing hospitalization, 90.3% for preventing ICU admission, and 86.3% for preventing death.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

Alina Tscherne et al.

Summary: The SARS-CoV-2 virus has caused the COVID-19 pandemic, and a recombinant MVA expressing the SARS-CoV-2 spike protein shows promise as a candidate for developing a COVID-19 vaccine.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Medicine, Research & Experimental

A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged mice

Alyssa Silva-Cayetano et al.

Summary: This study demonstrates that the ChAdOx1 nCoV-19 vaccine induces both cellular and humoral immunity in adult and aged mice, and suggests that a prime-boost strategy enhances immunogenicity in older individuals.

MED (2021)

添加到收藏夹

Review Immunology

Viral targets for vaccines against COVID-19

Lianpan Dai et al.

Summary: The urgent need for vaccines to control the COVID-19 pandemic has led to the rapid development of multiple vaccine candidates, with some showing positive results in late-stage clinical trials. This article discusses the viral elements used in these candidates, the reasons why they are good targets for the immune system, and their implications for protective immunity. Dai and Gao highlight the importance of selecting the right viral targets in vaccine development to ensure an effective immune response and the overall safety and efficacy of the vaccine.

NATURE REVIEWS IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

添加到收藏夹

Article Microbiology

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Alexander E. Gorbalenya et al.

NATURE MICROBIOLOGY (2020)

添加到收藏夹

Editorial Material Hematology

Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action

Anastasios Kollias et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Alba Grifoni et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

Shutoku Matsuyama et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Bin Ju et al.

NATURE (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti et al.

LANCET (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Noe B. Mercado et al.

NATURE (2020)

添加到收藏夹

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Denis Y. Logunov et al.

LANCET (2020)

添加到收藏夹

Article Immunology

Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Yanchun Peng et al.

NATURE IMMUNOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform

Flavia Chiuppesi et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots

Joachim Goedhart et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

Yingyao Zhou et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Sensitization with vaccinia virus encoding H5N1 hemagglutinin restores immune potential against H5N1 influenza virus

Fumihiko Yasui et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Article Pathology

Histopathological Evaluation of the Diversity of Cells Susceptible to H5N1 Virulent Avian Influenza Virus

Haru Ogiwara et al.

AMERICAN JOURNAL OF PATHOLOGY (2014)

添加到收藏夹

Review Virology

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases

Arwen F. Altenburg et al.

VIRUSES-BASEL (2014)

添加到收藏夹

Article Immunology

SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus

Masahiro Kitabatake et al.

VACCINE (2007)

添加到收藏夹

Article Virology

Structural analysis of vaccinia virus dls strain: Application as a new replication-deficient viral vector

K Ishii et al.

VIROLOGY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.